Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Spadaro

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Cancer|June 29, 2004
Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapyAtul Varadhachary, Jeffrey S Wolf, Karel Petrak, et al.
International Immunopharmacology|July 16, 2003
Immunization in tumor preventionGuido Forni, Claudia Curcio, Michela Spadaro, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2013
Recombinant human lactoferrin induces human and mouse dendritic cell maturation via Toll-like receptors 2 and 4Michela Spadaro, Monica Montone, Maddalena Arigoni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expressionTania Pannellini, Michela Spadaro, Emma Di Carlo, et al.
Frontiers in Immunology|March 13, 2018
The Footprints of Poly-Autoimmunity: Evidence for Common Biological Factors Involved in Multiple Sclerosis and Hashimoto's ThyroiditisSimona Perga, Serena Martire, Francesca Montarolo, et al.
Frontiers in Immunology|September 3, 2019
Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental TissueMichela Spadaro, Serena Martire, Luca Marozio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2010
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacySimona Rolla, Francesco Ria, Sergio Occhipinti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunityMichela Spadaro, Elena Ambrosino, Manuela Iezzi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamstersGiovanni N Berta, Andrea E Sprio, Manuela Iezzi, et al.
The Journal of Clinical Investigation|April 17, 2003
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomasClaudia Curcio, Emma Di Carlo, Raphael Clynes, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|June 29, 2004
Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapyAtul Varadhachary, Jeffrey S Wolf, Karel Petrak, et al.
International Immunopharmacology|July 16, 2003
Immunization in tumor preventionGuido Forni, Claudia Curcio, Michela Spadaro, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2013
Recombinant human lactoferrin induces human and mouse dendritic cell maturation via Toll-like receptors 2 and 4Michela Spadaro, Monica Montone, Maddalena Arigoni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expressionTania Pannellini, Michela Spadaro, Emma Di Carlo, et al.
Frontiers in Immunology|March 13, 2018
The Footprints of Poly-Autoimmunity: Evidence for Common Biological Factors Involved in Multiple Sclerosis and Hashimoto's ThyroiditisSimona Perga, Serena Martire, Francesca Montarolo, et al.
Frontiers in Immunology|September 3, 2019
Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental TissueMichela Spadaro, Serena Martire, Luca Marozio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2010
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacySimona Rolla, Francesco Ria, Sergio Occhipinti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunityMichela Spadaro, Elena Ambrosino, Manuela Iezzi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamstersGiovanni N Berta, Andrea E Sprio, Manuela Iezzi, et al.
The Journal of Clinical Investigation|April 17, 2003
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomasClaudia Curcio, Emma Di Carlo, Raphael Clynes, et al.
Pageof 3